REFERENCES
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., … Sunyaev, S. R. (2010). A method and server for predicting damaging missense mutations. Nature methods,7(4), 248–249. https://doi.org/10.1038/nmeth0410-248 Amberger, J. S., Bocchini, C. A., Scott, A. F., & Hamosh, A. (2019). OMIM.org: leveraging knowledge across phenotype-gene relationships.Nucleic acids research, 47(D1), D1038–D1043. https://doi.org/10.1093/nar/gky1151 Clark, M. M., Stark, Z., Farnaes, L., Tan, T. Y., White, S. M., Dimmock, D., & Kingsmore, S. F. (2018). Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. Npj Genomic Medicine, 3(1), 1–10. https://doi.org/10.1038/s41525-018-0053-8 Clift, K., Macklin, S., Halverson, C., McCormick, J. B., Abu Dabrh, A. M., & Hines, S. (2020). Patients’ views on variants of uncertain significance across indications. Journal of Community Genetics,11(2), 139–145. https://doi.org/10.1007/s12687-019-00434-7 Defesche, J. C., Gidding, S. S., Harada-Shiba, M., Hegele, R. A., Santos, R. D., & Wierzbicki, A. S. (2017). Familial hypercholesterolaemia. Nature Reviews. Disease Primers, 3, 17093. https://doi.org/10.1038/nrdp.2017.93 Evans W. R. (2018). Dare to think rare: diagnostic delay and rare diseases. The British journal of general practice : the journal of the Royal College of General Practitioners, 68(670), 224–225. https://doi.org/10.3399/bjgp18X695957 Fogel, B. L., Satya-Murti, S., & Cohen, B. H. (2016). Clinical exome sequencing in neurologic disease. Neurology. Clinical practice,6(2), 164–176. https://doi.org/10.1212/CPJ.0000000000000239 Gainotti, S., Mascalzoni, D., Bros-Facer, V., Petrini, C., Floridia, G., Roos, M., … Taruscio, D. (2018). Meeting Patients’ Right to the Correct Diagnosis: Ongoing International Initiatives on Undiagnosed Rare Diseases and Ethical and Social Issues. International journal of environmental research and public health, 15(10), 2072. https://doi.org/10.3390/ijerph15102072 Ghosh, R., Oak, N., & Plon, S. E. (2017). Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines. Genome Biology, 18(1), 1–12. https://doi.org/10.1186/s13059-017-1353-5 Hoffman-Andrews, L. (2017). The known unknown: The challenges of genetic variants of uncertain significance in clinical practice. Journal of Law and the Biosciences, 4(3), 648–657. https://doi.org/10.1093/jlb/lsx038 Ioannidis, N. M., Rothstein, J. H., Pejaver, V., Middha, S., McDonnell, S. K., Baheti, S., … Sieh, W. (2016). REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.American Journal of Human Genetics, 99(4), 877–885. https://doi.org/10.1016/j.ajhg.2016.08.016 Ionita-Laza, I., Mccallum, K., Xu, B., & Buxbaum, J. D. (2016). A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nature Genetics, 48(2), 214–220. https://doi.org/10.1038/ng.3477 Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., … Vichinsky, E. P. (2018). Sickle cell disease.Nature reviews. Disease primers, 4, 18010. https://doi.org/10.1038/nrdp.2018.10 Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., … Maglott, D. R. (2018). ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Research, 46(D1), D1062–D1067. https://doi.org/10.1093/nar/gkx1153 Liu, X., Wu, C., Li, C., & Boerwinkle, E. (2016). dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs. Human Mutation, 37(3), 235–241. https://doi.org/10.1002/humu.22932 McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., …Cunningham, F. (2016). The Ensembl Variant Effect Predictor. Genome Biology, 17(1), 1–14. https://doi.org/10.1186/s13059-016-0974-4 Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., … Ledbetter, D. H. (2010). Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies. American Journal of Human Genetics, 86(5), 749–764. https://doi.org/10.1016/j.ajhg.2010.04.006 Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., & Kircher, M. (2019). CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research, 47(D1), D886–D894. https://doi.org/10.1093/nar/gky1016 Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., … Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405–424. https://doi.org/10.1038/gim.2015.30 Strausbaugh, S. D., & Davis, P. B. (2007). Cystic Fibrosis: A Review of Epidemiology and Pathobiology. Clinics in Chest Medicine,28(2), 279–288. https://doi.org/10.1016/j.ccm.2007.02.011 Sun, S., Weile, J., Verby, M., Wu, Y., Wang, Y., Cote, A. G., … Roth, F. P. (2020). A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase. Genome medicine, 12(1), 13. https://doi.org/10.1186/s13073-020-0711-1 Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M., & Ng, P. C. (2016). SIFT missense predictions for genomes. Nature Protocols,11(1), 1–9. https://doi.org/10.1038/nprot.2015.123 Walsh, R., Mazzarotto, F., Whiffin, N., Buchan, R., Midwinter, W., Wilk, A., … Ware, J. S. (2019). Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: The case of hypertrophic cardiomyopathy.Genome Medicine, 11(1), 1–18. https://doi.org/10.1186/s13073-019-0616-z Weile, J., & Roth, F. P. (2018). Multiplexed assays of variant effects contribute to a growing genotype–phenotype atlas. Human Genetics, 137(9), 665–678. https://doi.org/10.1007/s00439-018-1916-x Zeng, Z., & Bromberg, Y. (2019). Predicting Functional Effects of Synonymous Variants: A Systematic Review and Perspectives.Frontiers in genetics, 10, 914. https://doi.org/10.3389/fgene.2019.00914 Zerbino, D. R., Achuthan, P., Akanni, W., Amode, M. R., Barrell, D., Bhai, J., … Flicek, P. (2018). Ensembl 2018. Nucleic Acids Research, 46(D1), D754–D761. https://doi.org/10.1093/nar/gkx1098